MYPN Gene Cardiomyopathy dilated type 1KK Genetic Test
Welcome to DNA Labs UAE, where we offer the MYPN Gene Cardiomyopathy dilated type 1KK Genetic Test. This genetic test analyzes the MYPN gene for mutations associated with dilated cardiomyopathy (DCM).
Test Details
The MYPN gene cardiomyopathy, dilated type 1KK NGS genetic test is a genetic test that analyzes the MYPN gene for mutations associated with dilated cardiomyopathy (DCM). DCM is a condition characterized by the enlargement of the heart chambers, leading to reduced pumping ability and potential heart failure.
The MYPN gene provides instructions for producing the protein myopalladin, which is involved in the structure and function of heart muscle cells. Mutations in the MYPN gene have been linked to DCM, and this genetic test aims to identify these mutations.
NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the rapid analysis of multiple genes simultaneously. This test uses NGS to sequence the MYPN gene and identify any potential disease-causing mutations.
The results of the MYPN gene cardiomyopathy, dilated type 1KK NGS genetic test can help diagnose individuals with DCM caused by MYPN gene mutations. This information can be useful for personalized treatment and management of the condition. Additionally, it may provide valuable information for family members who may be at risk of inheriting the mutation.
It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as genetic counselors or medical geneticists, to ensure accurate results and appropriate clinical management.
Test Components and Price
- Test Name: MYPN Gene Cardiomyopathy dilated type 1KK Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Cardiovascular Pneumology Disorders
- Doctor: Cardiologist
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for MYPN Gene Cardiomyopathy, dilated type 1KK NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYPN Gene Cardiomyopathy, dilated type 1KK NGS Genetic DNA Test gene MYPN
At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. Contact us today to schedule your MYPN Gene Cardiomyopathy dilated type 1KK Genetic Test.
| Test Name | MYPN Gene Cardiomyopathy dilated type 1KK Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MYPN Gene Cardiomyopathy, dilated type 1KK NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYPN Gene Cardiomyopathy, dilated type 1KK NGS Genetic DNA Test gene MYPN |
| Test Details |
MYPN gene cardiomyopathy, dilated type 1KK NGS genetic test is a genetic test that analyzes the MYPN gene for mutations associated with dilated cardiomyopathy (DCM). DCM is a condition characterized by the enlargement of the heart chambers, leading to reduced pumping ability and potential heart failure. The MYPN gene provides instructions for producing the protein myopalladin, which is involved in the structure and function of heart muscle cells. Mutations in the MYPN gene have been linked to DCM, and this genetic test aims to identify these mutations. NGS (Next-Generation Sequencing) is a high-throughput DNA sequencing technology that allows for the rapid analysis of multiple genes simultaneously. This test uses NGS to sequence the MYPN gene and identify any potential disease-causing mutations. The results of the MYPN gene cardiomyopathy, dilated type 1KK NGS genetic test can help diagnose individuals with DCM caused by MYPN gene mutations. This information can be useful for personalized treatment and management of the condition. Additionally, it may provide valuable information for family members who may be at risk of inheriting the mutation. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as genetic counselors or medical geneticists, to ensure accurate results and appropriate clinical management. |
